Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

Addiction Medicine

Inside the pharmacodynamics and presentation of loperamide including potential abuse and related patient behaviors.
Basic principles in urine drug monitoring (UDM) are reviewed and applied to a patient testing positive for oxycodone and amphetamine.
Withdrawal and craving scores for the buprenorphine product remained constant and consistently lower than placebo.
Where the states are exceeding, and what they can do to improve.
Recently FDA-approved, reSET-O encourages CBT guidelines to coincide with opioid use disorder treatment.
Strategies for ordering, understanding, and communicating opioid therapy screening results.
With Lindsey Vuolo, JD, MPH, Paul George, MD, MPHE, Josiah Rich, MD, MPH, and Jeff Gud
FDA makes a motion to increase medication-assisted treatment for opioid addiction.
Gaining clearance from the Food and Drug Administration (FDA), 2 new drug screening tests offer practitioner immediate, in-office results for the 5 most commonly abused opioid-derived drugs and for fentanyl.
President Trump established a new commission to combat opioid addiction, taps Governor Chris Christie to head--Practical Pain Management gets reaction from physicians in the field.
Drug-seeking behaviors may be very similar to those presented in patients with inadequately controlled pain.
New research suggests that deep brain stimulation of the brain (subthalamic nucleus) may reduce heroin abuse in an animal model.
New SAMHSA smartphone app provides doctors instant access to resources for medication assisted treatment (MAT).
Survey finds that many clinicians have negative attitudes about opioid addiction, often blaming the patient. Learn more about the new national survey.
HHS takes steps to stem tide of opioid-related overdose, death, and dependence.
close X